![Daniel Lochner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Lochner
Geen lopende functies
Vermogen: 2 M $ op 31-05-2026
Profiel
Daniel Lochner is currently Chief Financial Officer at Tectonic Therapeutic, Inc. and Chief Financial Officer at Tectonic Operating Co., Inc., both starting in 2024.
Former positions include Chief Financial Officer at AVROBIO, Inc. in 2024, Chief Financial & Business Officer-Eye Care at Viatris, Inc. from 2023 to 2024, Chief Financial & Business Officer at Oyster Point Pharma, Inc. from 2022 to 2023, and Portfolio Manager at Goldman Sachs Asset Management LP from 2005 to 2019.
Education includes an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of Richmond.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,31% | 11-06-2026 | 58.544 ( 0,31% ) | 2 M $ | 31-05-2026 |
Actieve functies van Daniel Lochner
| Bedrijven | Functie | Begin |
|---|---|---|
Tectonic Therapeutic, Inc.
 Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company that transforming the discovery of novel G-protein-coupled receptors targeted therapies | Financieel Directeur/CFO | 01-06-2024 |
Eerdere bekende functies van Daniel Lochner
| Bedrijven | Functie | Einde |
|---|---|---|
| VIATRIS INC. | Corporate Officer/Principal | 01-04-2024 |
| OYSR POIN | Financieel Directeur/CFO | 01-01-2023 |
Goldman Sachs Asset Management LP
 Goldman Sachs Asset Management LP Investment ManagersFinance GSMALP offers a wide array of investment strategies that span asset classes, industries, and geographies. The firm's products and services across a full range of asset classes including fixed income, money markets, public and private equity, commodities, hedge funds, and real estate. Clients access these solutions through GSAM's proprietary strategies, strategic partnerships, and open architecture programs. | Portefeuillebeheerder-Aandelen | 01-07-2019 |
| TECTONIC THERAPEUTIC, INC. | Financieel Directeur/CFO | - |
Opleiding van Daniel Lochner
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
75
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Goldman Sachs Asset Management LP
Goldman Sachs Asset Management LP Investment ManagersFinance GSMALP offers a wide array of investment strategies that span asset classes, industries, and geographies. The firm's products and services across a full range of asset classes including fixed income, money markets, public and private equity, commodities, hedge funds, and real estate. Clients access these solutions through GSAM's proprietary strategies, strategic partnerships, and open architecture programs. | Finance |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Richmond
 University of Richmond Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
Oyster Point Pharma, Inc.
 Oyster Point Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops and commercializes pharmaceutical therapies to treat ocular surface diseases | Commercial Services |
Viatris, Inc.
 Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company that transforming the discovery of novel G-protein-coupled receptors targeted therapies | Commercial Services |
Kies MarketScreener 
